Zobrazeno 1 - 10
of 276
pro vyhledávání: '"George E Wright"'
Autor:
Hung Chang, Ivan B Yanachkov, Edward J Dix, Milka Yanachkova, Youfu Li, Marc R Barnard, George E Wright, Alan D Michelson, Andrew L Frelinger
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94780 (2014)
Diadenosine tetraphosphate (Ap4A), a constituent of platelet dense granules, and its P1,P4-dithio and/or P2,P3-chloromethylene analogs, inhibit adenosine diphosphate (ADP)-induced platelet aggregation. We recently reported that these compounds antago
Externí odkaz:
https://doaj.org/article/874ef7e91dfb4fdb80321881bbbe4d83
Autor:
Dean Bryant, George E. Wright, James S. Blachly, Jonathan C. Strefford, Graham Packham, Carl G. Figdor, Francesco Forconi, Isla Henderson, Thomas A. Bowden, Giorgia Chiodin, Teunis B. H. Geijtenbeek, Beatriz Valle-Argos, Philip J. Rock, Enrica Antonia Martino, Patrick J. Duriez, Freda K. Stevenson, Yasunori Watanabe, Katy J. McCann, Louis M. Staudt, Max Crispin, Joel D. Allen, Richard Burack
Publikováno v:
Blood, 138(17), 1570-1582. American Society of Hematology
Blood, 138, 17, pp. 1570-1582
Blood, 138, 1570-1582
Blood
Blood, 138, 17, pp. 1570-1582
Blood, 138, 1570-1582
Blood
Glycosylation of the surface immunoglobulin (Ig) variable region is a remarkable follicular lymphoma–associated feature rarely seen in normal B cells. Here, we define a subset of diffuse large B-cell lymphomas (DLBCLs) that acquire N-glycosylation
Autor:
Louis M. Staudt, Carmen Doebele, Hang Nguyen, Arthur L. Shaffer, Angelika Oellerich, Yanlong Ji, Thomas Oellerich, George E. Wright, Samantha Schaller, Sebastian Scheich, Richard Longnecker, Jagan R. Muppidi, Kuan-Ting Pan, Henning Urlaub, Kamonwan Fish, Hubert Serve, Federico Comoglio, Masato Ikeda
Publikováno v:
Proc Natl Acad Sci U S A
Epstein-Barr virus (EBV) infects human B cells and reprograms them to allow virus replication and persistence. One key viral factor in this process is latent membrane protein 2A (LMP2A), which has been described as a B cell receptor (BCR) mimic promo
Autor:
Louis M. Staudt, Christopher Melani, Da-Wei Huang, Alina Nicolae, Stefania Pittaluga, Seth M. Steinberg, George E. Wright, Elaine S. Jaffe, Wyndham H. Wilson, Mark Roschewski
Publikováno v:
Blood Cancer Discov
Mediastinal gray zone lymphoma (MGZL) has immunopathologic features between classical Hodgkin lymphoma (cHL) and primary mediastinal thymic B-cell lymphoma (PMBL), leading to uncertainty regarding its biological relationship to these entities. We per
Publikováno v:
Comparative Medicine. 70:56-66
Zoonotic monkey B virus (Macacine alphaherpesvirus 1; BV) infections are extremely serious and usually fatal. Drugs currently used for treatment were developed for the treatment of herpes simplex virus but are less effective against BV. Effective sup
Autor:
Frances A. Tosto, Ping Chen, Dickran Kazandjian, Craig J. Thomas, George E. Wright, Kelli M. Wilson, Thomas Oellerich, James W. Lord, Carleen Klumpp-Thomas, Irina Maric, Grace Smith, Crystal McKnight, Da-Wei Huang, Jan Wisnieski, Xin Yu, Ryan M. Young, Björn Häupl, Michele Ceribelli, Arnold Bolomsky, James Q. Wang, Erin S Beck, Callie K. Van Winkle, Jameson Travers, James D. Phelan, Stefania Pittaluga, Yandan Yang
Publikováno v:
Nature communications. 13(1)
Oncogenic mutations within the RAS pathway are common in multiple myeloma (MM), an incurable malignancy of plasma cells. However, the mechanisms of pathogenic RAS signaling in this disease remain enigmatic and difficult to inhibit therapeutically. We
Autor:
Michael C. Kelly, Xiaohu Zhang, Kelli M. Wilson, Erika M Gaglione, Inhye E. Ahn, Zachary Rae, Lu Chen, Louis M. Staudt, Weihong Xu, Yandan Yang, James D. Phelan, Sandrine Roulland, Dan E. Webster, Arthur L. Shaffer, Björn Häupl, Hong Zhao, Xin Yu, Clare Sun, George E. Wright, Jaewoo Choi, Crystal McKnight, Da-Wei Huang, Craig J. Thomas, Ryan M. Young, Monica Kasbekar, James Q. Wang, Thomas Oellerich, Wyndham H. Wilson, Carleen Klumpp-Thomas, Adrian Wiestner, Michele Ceribelli
Publikováno v:
Blood Cancer Discov
The use of Bruton tyrosine kinase (BTK) inhibitors to block B-cell receptor (BCR)–dependent NF-κB activation in lymphoid malignancies has been a major clinical advance, yet acquired therapeutic resistance is a recurring problem. We modeled the dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aac385850371cd627d809df8da7e0a54
https://europepmc.org/articles/PMC8580621/
https://europepmc.org/articles/PMC8580621/
Autor:
Louis M. Staudt, Roland Schmitz, Thomas Oellerich, Wyndham H. Wilson, George E. Wright, Ryan M. Young, James D. Phelan, Calvin A. Johnson, Arthur L. Shaffer, Da-Wei Huang
Publikováno v:
Annual Review of Cancer Biology. 3:429-455
Genomic analyses of diffuse large B cell lymphoma (DLBCL) are revealing the genetic and phenotypic heterogeneity of these aggressive lymphomas. In part, this heterogeneity reflects the existence of distinct genetic subtypes that acquire characteristi
Autor:
Brendan Hodkinson, Louis M. Staudt, George E. Wright, Martin Shreeve, Sriram Balasubramanian, Yue Fan, Wyndham H. Wilson, Da-Wei Huang, Jessica Vermeulen
Publikováno v:
Cancer cell. 39(12)
Summary In diffuse large B cell lymphoma (DLBCL), tumors belonging to the ABC but not GCB gene expression subgroup rely upon chronic active B cell receptor signaling for viability, a dependency that is targetable by ibrutinib. A phase III trial (“P
Autor:
Louis M. Staudt, Amy S. Kimball, Sven de Vos, Jerry Ping, Darrin M. Beaupre, Wyndham H. Wilson, Da-Wei Huang, Kevin A. Kwei, George E. Wright, Leslie Popplewell, Jutta K. Neuenburg, Saurabh Chhabra, Tycel Phillips
Publikováno v:
Leukemialymphoma. 62(9)
Relapsed/refractory diffuse large B-cell lymphoma (DLBCL) is difficult to cure; non-germinal center B-cell-like (non-GCB) and activated B-cell-like (ABC) DLBCL have worse outcomes than GCB DLBCL. Ibrutinib and lenalidomide are synergistic in vitro in